Valuation genOway

Stocks

Market Closed - Euronext Paris 01:55:00 12/09/26 am AEST			5-day change	1st Jan Change
2.470 ^EUR	-1.20%		-0.40%	-8.86%

31/03	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
31/12	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.45	37.85	35.3	40.59	34.58	24.99
Change	-	76.49%	-6.76%	15%	-14.82%	-27.73%
Enterprise Value (EV) ¹	29.49	43.07	39.45	43.56	35.2	31.7
Change	-	46.05%	-8.41%	10.42%	-19.2%	-9.93%
P/E	-	-	-	-	-	-
PBR	-	-	-	-	-	-
PEG	-	-	-	-	-	-
Capitalization / Revenue	1.32x	1.93x	1.67x	1.53x	1.26x	0.87x
EV / Revenue	1.81x	2.2x	1.87x	1.64x	1.28x	1.11x
EV / EBITDA	34.9x	99.8x	13.1x	7.49x	9.04x	7.16x
EV / EBIT	-78.2x	-54.6x	80.7x	27.8x	27x	24.9x
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-
Net sales ¹	16.29	19.59	21.09	26.51	27.53	28.6
EBITDA ¹	0.844	0.4318	3.006	5.815	3.894	4.428
EBIT ¹	-0.3771	-0.7893	0.4886	1.565	1.304	1.274
Net income ¹	-0.6873	-0.3226	0.7778	1.568	1.831	0.9278
Net Debt ¹	8.045	5.22	4.156	2.973	0.623	6.718
Reference price ²	3.100	4.290	4.000	4.600	3.750	2.710
Nbr of stocks (in thousands)	6,919	8,824	8,824	8,824	9,220	9,220
Announcement Date	28/4/22	28/4/22	28/4/23	1/5/24	29/4/25	30/4/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOWAY	-	-	-	-	26.43M
LONZA GROUP AG	31.04x	5.6x	16.76x	1.05%	45.48B
REVOLUTION MEDICINES, INC.	-20.85x	240.83x	-22.36x	-.--%	43.69B
IQVIA HOLDINGS INC.	33.71x	3.27x	14.1x	-.--%	43.09B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	27.03x	8.15x	20.66x	0.42%	31.91B
MEDPACE HOLDINGS, INC.	33.41x	5.47x	24.85x	-.--%	16.4B
EUROFINS SCIENTIFIC SE	23.57x	2.06x	8.94x	1.13%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.44x	3.94x	15.27x	-.--%	13.28B
Average	30.97x	34.32x	13.36x	0.33%	27.5B
Weighted average by Cap.	26.17x	46.69x	11.79x	0.31%